Drug Name:Adalimumab
Drug Class:TNF-alpha inhibitor
Mechanism of Action:
  • Binds to TNF-alpha and blocks its activity
  • Reduces inflammation and immune response
Use:
  • Rheumatoid arthritis
  • Psoriatic arthritis
  • Ankylosing spondylitis
  • Crohn's disease
  • Ulcerative colitis
  • Plaque psoriasis
Side Effects:
  • Injection site reactions
  • Headache
  • Nausea
  • Upper respiratory infections
  • Increased risk of infections
  • Increased risk of lymphoma and other cancers
Contraindications:
  • Active infections
  • Hypersensitivity to adalimumab or any component of the formulation
Specialty:
  • Rheumatology
  • Gastroenterology
  • Dermatology